Clinical Trial Consultants (CTC) supports customers with hospital-based early phase clinical trials, including patient recruitment, trial design, implementation and data evaluation.
The newly launched Recipharm Pathway to Clinic will take projects from early phase formulation development through clinical trial implementation, according to the company.
“We have worked together on various projects in the past and found that the partnership works well,” Torkel Gren, general manager at Recipharm Pharmaceutical Development AB told Outsourcing-Pharma.com.
In 2014, the companies teamed up in a collaboration focused on producing materials for Phase I clinical trials.
Additionally, CTC’s site in Uppsala is geographically close to Recipharm’s sites in Uppsala and Solna, at which the CDMO performs formulation development, GMP clinical supply manufacture, and bioanalysis.
The proximity will facilitate the transfer of clinical trial material and samples, said Gren.
“We can offer our customers a start to finish service, which reduces the complexity of first in human studies for them and speed the process up as a result of seamless coordination with Recipharm providing clinical trial material and CTC planning and conducting the actual study,” he added.
Recipharm will also analyze samples during or after trial completion.
As for the next steps, Gren said the company will hopefully be able to build on the current offering to help customers with bioequivalence studies and bioavailability studies as well as first in human studies.